Literature DB >> 28823888

Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.

Ankit Saneja1, Robin Kumar2, Amarinder Singh3, Ravindra Dhar Dubey4, Mubashir J Mintoo5, Gurdarshan Singh6, Dilip M Mondhe7, Amulya K Panda8, Prem N Gupta9.   

Abstract

The clinical application of betulinic acid (BA), a natural pentacyclic triterpenoid with promising antitumor activity, is hampered due to its extremely poor water solubility and relatively short half-life in the systemic circulation. In order to address these issues, herein, we developed betulinic acid loaded polylactide-co-glycolide- monomethoxy polyethylene glycol nanoparticles (PLGA-mPEG NPs). The PLGA-mPEG co-polymer was synthesized and characterized using NMR and FT-IR. BA loaded PLGA-mPEG NPs were prepared by an emulsion solvent evaporation method. The developed nanoparticles had a desirable particle size (∼147nm) and exhibited uniform spherical shape under transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The PLGA-mPEG NPs were able to decrease the uptake by macrophages (i.e. J774A.1 and Raw 264.7 cells) as compared to PLGA nanoparticles. In vitro cytotoxicity in MCF7 and PANC-1 cells demonstrated enhanced cytotoxicity of BA loaded PLGA-mPEG NPs as compared to free BA. The cellular uptake study in both the cell lines demonstrated time dependent uptake behavior. The enhanced cytotoxicity of BA NPs was also supported by increased cellular apoptosis, mitochondrial membrane potential loss, generation of high reactive oxygen species (ROS) and cell cycle arrest. Further, intravenous pharmacokinetics study revealed that BA loaded PLGA-mPEG NPs could prolong the circulation of BA and remarkably enhance half-life by ∼7.21 folds. Consequently, in vivo studies in Ehrlich tumor (solid) model following intravenous administration demonstrated superior antitumor efficacy of BA NPs as compared to native BA. Moreover, BA NPs treated Ehrlich tumor mice demonstrated no biochemical, hematological and histological toxicities. These findings collectively indicated that the BA loaded PLGA-mPEG NPs might serve as a promising nanocarrier for improved therapeutic efficacy of betulinic acid.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Betulinic acid; Betulinic acid (PubChem CID: 64971); Dicyclohexylcarbodiimide (PubChem CID: 10868); Ehrlich tumor; N-hydroxysuccinimide (PubChem CID: 80170); Nanoparticle; Pharmacokinetics; Poly (dl-lactic-co-glycolic acid) (PubChem CID: 23111554)

Mesh:

Substances:

Year:  2017        PMID: 28823888     DOI: 10.1016/j.ijpharm.2017.08.076

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.

Authors:  Zi Chao Wu; Xin Yu Liu; Jia Yan Liu; Jing Shu Piao; Ming Guan Piao
Journal:  Int J Nanomedicine       Date:  2022-09-14

2.  Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.

Authors:  Shuqi Li; Jie Zhang; Yuqi Fang; Jun Yi; Zhufen Lu; Yanzhong Chen; Bohong Guo
Journal:  Drug Des Devel Ther       Date:  2020-01-16       Impact factor: 4.162

3.  Enhancement of the Antioxidant and Skin Permeation Properties of Betulin and Its Derivatives.

Authors:  Andrzej Günther; Edyta Makuch; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Robert Pełech; Adam Klimowicz
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

4.  Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus.

Authors:  Ali Khamesipour; Amitis Ramezani; Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Hasan Ebrahimi Shahmabadi; Mostafa Haji Molla Hoseini; Nariman Mosaffa
Journal:  Int J Nanomedicine       Date:  2019-09-24

Review 5.  Natural Biocidal Compounds of Plant Origin as Biodegradable Materials Modifiers.

Authors:  Alona Pawłowska; Magdalena Stepczyńska
Journal:  J Polym Environ       Date:  2021-10-23       Impact factor: 4.705

Review 6.  Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review.

Authors:  Sofia Teixeira; Maria Alice Carvalho; Elisabete M S Castanheira
Journal:  Biomedicines       Date:  2022-02-18

7.  Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels.

Authors:  Shreya S Bellampalli; Yingshi Ji; Aubin Moutal; Song Cai; E M Kithsiri Wijeratne; Maria A Gandini; Jie Yu; Aude Chefdeville; Angie Dorame; Lindsey A Chew; Cynthia L Madura; Shizhen Luo; Gabriella Molnar; May Khanna; John M Streicher; Gerald W Zamponi; A A Leslie Gunatilaka; Rajesh Khanna
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

8.  Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.

Authors:  Xinyi Yuan; Fuhuan Fei; Huanmei Sun; Chaoni Xiao; Xinfeng Zhao; Yajun Zhang; Xiaohui Zheng
Journal:  Int J Nanomedicine       Date:  2018-04-12

9.  Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney.

Authors:  Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Mostafa Haji Molla Hoseini; Ali Khamesipour; Nariman Mosaffa; Amitis Ramezani
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

10.  Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes.

Authors:  Samrat Chakraborty; Zewdu Yilma Dlie; Somdyuti Chakraborty; Somdatta Roy; Biswajit Mukherjee; Shila Elizabeth Besra; Saikat Dewanjee; Alankar Mukherjee; Probir Kumar Ojha; Vinay Kumar; Ramkrishna Sen
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-05       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.